Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrimal duct surgery, and corneal diseases treatment, as well as low vision and visual rehabilitation. It is also involved in medical, hospital, and investment management; ophthalmological research; sale of medical instruments and eyeglasses; cultural propagation; engineering renovation; and technology development. The company was formerly known as Chengdu Bright Eye Hospital Group Co., Ltd. and changed its name to Bright Eye Hospital Group Co., Ltd. in June 2025. Bright Eye Hospital Group Co., Ltd. was founded in 2005 and is headquartered in Chengdu, China.
Frequently asked questions
What sector does Chengdu Bright Eye Hospital Co. Ltd. (301239) operate in?
Chengdu Bright Eye Hospital Co. Ltd. belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Chengdu Bright Eye Hospital Co. Ltd. (301239) current stock price?
As of the latest data, Chengdu Bright Eye Hospital Co. Ltd. stock price is CN¥36.70, with a previous close of CN¥36.49. Chengdu Bright Eye Hospital Co. Ltd. gained CN¥0.21 in the last trading session, representing a 0.58% increase.
What is Chengdu Bright Eye Hospital Co. Ltd. (301239) current market capitalization?
Chengdu Bright Eye Hospital Co. Ltd. market cap is approximately 5.49 billion.
What is Chengdu Bright Eye Hospital Co. Ltd. (301239) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.12, and the forward EPS is CN¥0.98.
Does Chengdu Bright Eye Hospital Co. Ltd. (301239) pay dividends?
No. Chengdu Bright Eye Hospital Co. Ltd. does not pay a dividend.
What is Chengdu Bright Eye Hospital Co. Ltd. (301239) beta (volatility) score?
Chengdu Bright Eye Hospital Co. Ltd. has a beta of 0.673, indicating lower volatility than the overall market.
